Can Your Clinical Data Strategy Keep Pace?

By Nach Davé and Stacy Weil

The current state of clinical research

Businesses around the world are being challenged to evolve due to recent events, and the clinical trial industry is no exception. However, many of these changes were already underway prior to the pandemic; COVID-19 has accelerated these innovations rather than initiated them.

The clinical research environment has been impacted in multiple ways, ranging from new regulatory requirements to supply chain interruptions and shipping delays. In addition, many of the standard clinical trial logistics are being reassessed. For example, patients are becoming much more comfortable with mobile health (mHealth) devices, accelerating plans for remote data capture, analysis, and sharing.

Following up on our recent webinar Setting a Real-World Strategy in an Evolving Clinical Research Environment, this is the first of two blogs on this critical topic. In this post, we’ll cover the importance of process in ensuring a robust strategy is in place for the acquisition and analysis of trial data in the face of a changing clinical research environment.